Do you put weight back on when you stop Mounjaro?

Picture this: your last pen is gone and the hunger comes back

You've been on Mounjaro for several months. The appetite that felt relentless has been quiet. You're eating less without trying, moving more, and the scale is finally going in the right direction. Then, for whatever reason (cost, a planned break, a clinical decision) you take your last dose.

Within days, many people notice a shift. Not dramatic at first. Appetite edges back. The feeling of fullness after a small meal fades. Food starts occupying more mental space than it did a few weeks ago. This is not imagination. Tirzepatide works partly by activating the GLP-1 and GIP receptors that regulate hunger and gastric emptying; once the medicine clears, those signals return to their pre-treatment pattern. The NHS medicine page for tirzepatide notes that Mounjaro is intended to be used alongside a reduced-calorie diet and increased physical activity as part of a longer-term approach, not as a short course.

The practical upshot: the medicine was doing some of the heavy lifting. When it stops, you carry more of the load yourself. How much weight you regain depends on what load you're ready to carry.

What the clinical data actually shows about weight coming back

Evidence from related GLP-1 research is instructive here. A large withdrawal study of semaglutide (a close relative, and the active ingredient in Wegovy, which is also available through our treatment team) found that participants regained about two-thirds of their lost weight within a year of stopping, while those who continued on the medicine maintained their losses. Tirzepatide-specific withdrawal data is more limited, but the biological mechanism is similar (dual GIP and GLP-1 receptor activation, as described in NICE's appraisal of tirzepatide (TA1026)) and there is no strong reason to expect a fundamentally different pattern.

Regain tends to accelerate in the first six months after stopping, then slow. The total amount varies significantly by individual: someone who used the treatment to build lasting habits may regain far less than someone who treated it as a standalone fix. Protein intake, resistance training and a sustainable calorie awareness during treatment are among the factors that seem to blunt the rebound, though no lifestyle change fully replaces the medicine's effect on appetite signalling.

One simple habit worth building now, while still on treatment: weigh yourself once a week at the same time of day, ideally on a Monday morning before breakfast. A trend over four to six weeks tells you far more than a single reading, and catching a steady upward drift early gives you the most options.

Why the biology makes this hard, and what that means for your plan

Obesity is increasingly understood as a condition with strong physiological drivers — not a decision, not a character trait. The body defends its higher weight through multiple hormonal and metabolic pathways. Tirzepatide addresses several of them simultaneously; stopping it removes those interventions. This is why the question of weight returning after Mounjaro is not really about whether you 'did it right' during treatment.

The implication is practical. If you are considering stopping, the most useful conversation you can have is with a prescriber about what comes next, not just what to do on the last dose. Options might include a planned taper, a transition to a lower maintenance dose, a structured lifestyle programme, or simply a clear monitoring plan. For people approaching their target weight on Mounjaro, some clinicians discuss extending treatment to help consolidate the loss before any withdrawal attempt.

If you are already off Mounjaro and noticing weight creeping back, that is also worth discussing with a prescriber, and you may find it helpful to read what others have shared in their Mounjaro recenzii about managing this transition. Restarting treatment is a clinical decision, but it is a legitimate one, and regain is one of the recognised reasons someone might be appropriate for a further course. The tirzepatide overview on our site covers more on who the medicine is licensed for and how private treatment works.

The role of a prescriber when you're thinking about stopping

Stopping a prescription medicine because the cost has become a concern is understandable. Prices have changed considerably; you can read about how Eli Lilly's UK price increase has affected private treatment costs and what that means in practice. But the decision should involve your prescribing team rather than simply not reordering, partly because an abrupt stop with no plan is more likely to lead to rapid regain than a managed approach, and partly because there may be options you have not considered.

At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber, and that applies to reviews too, not just first prescriptions. If you are worried about what stopping means for your weight, our frequently asked questions cover some of the basics, or you can reach our aftercare team directly. There are no auto-renewals and no pressure to continue; the clinical review exists to help you make the right decision for your situation, whatever that looks like.